Amandine Masseron
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 6
- Endocrinology top 10%
- Escherichia coli research studies 1
- Vibrio bacteria research studies 1
-
- Antibiotics Pharmacokinetics and Efficacy 2
-
- Plant Pathogenic Bacteria Studies 2
-
- SARS-CoV-2 and COVID-19 Research 1
-
- Bacterial Identification and Susceptibility Testing 1
-
- Cancer therapeutics and mechanisms 1
- Co-authors
- Patrice NordmannLaurent PoirelGilbert GreubTatiana GalpérineGuy Prod’homLinda MuellerMario JuhasSimon Tiziani
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Diagnostic Microbiology and Infectious Disease (1 paper)Water Research (1 paper)
- Partner nations
- SwitzerlandFranceAustria
In The Last Decade
Amandine Masseron
7 papers receiving 175 citations
Peers
Comparison fields: 5 of 26
- Molecular Medicine 160
- Applied Microbiology and Biotechnology 46
- Endocrinology 61
- Pharmacology 81
- Pollution 30
Countries citing papers authored by Amandine Masseron
This map shows the geographic impact of Amandine Masseron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amandine Masseron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amandine Masseron more than expected).
Fields of papers citing papers by Amandine Masseron
This network shows the impact of papers produced by Amandine Masseron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amandine Masseron. The network helps show where Amandine Masseron may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amandine Masseron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 14 | |
| 2 | 2020 | 14 | |
| 3 | 2020 | 37 | |
| 4 | 2019 | 20 | |
| 5 | 2019 | 17 | |
| 6 | 2019 | 62 | |
| 7 | 2019 | 15 |
About Amandine Masseron
Amandine Masseron is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Endocrinology, Clinical Biochemistry and Pharmacology, having authored 7 papers that have together received 179 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Plant Pathogenic Bacteria Studies (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper), Bacterial Identification and Susceptibility Testing (1 paper), Cancer therapeutics and mechanisms (1 paper), Escherichia coli research studies (1 paper) and Vibrio bacteria research studies (1 paper). The work is most often cited by research in Molecular Medicine (160 citations), Applied Microbiology and Biotechnology (46 citations), Endocrinology (61 citations), Pharmacology (81 citations) and Pollution (30 citations). Amandine Masseron has collaborated with scholars based in Switzerland, France and Austria. Frequent co-authors include Patrice Nordmann, Laurent Poirel, Gilbert Greub, Tatiana Galpérine, Guy Prod’hom, Linda Mueller, Mario Juhas, Simon Tiziani, Stefano Mancini and Vincent Perreten. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Diagnostic Microbiology and Infectious Disease, Water Research, Journal of Global Antimicrobial Resistance and New Microbes and New Infections.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.